All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

GE HealthCare Unveils AI and Radiopharmaceutical Innovations to Expand Nuclear Medicine Access at SNMMI 2026

By

Stock Titan Editorial Team

1h ago· 11 min readen

Summary

GE HealthCare is showcasing new AI-enabled workflows, radiopharmaceuticals, and imaging innovations at the 2026 SNMMI Annual Meeting to help healthcare systems scale nuclear medicine operations amid rapid growth in theranostics and radiopharmaceutical demand. The global nuclear medicine market is projected to grow from $7.8B in 2024 to $30.7B by 2034. The company's focus spans precision diagnostics, therapeutic tracers, and AI-driven efficiency improvements across the nuclear medicine care pathway.

Key quotes

· 3 pulled
As theranostics adoption accelerates and radiopharmaceutical demand grows, healthcare systems are under increasing pressure to scale nuclear medicine operations while improving diagnostic confidence and workflow efficiency.
At the 2026 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare showcases its latest technologies and AI-enabled workflows to help support precision care across care pathways.
Global nuclear medicine market set to grow from $7.8B in 2024 to $30.7B by 2034
Snippet from the RSS feed
Global nuclear medicine market set to grow from $7.8B in 2024 to $30.7B by 2034; GE HealthCare showcases AI workflows, tracers and imaging to expand access.

You might also wanna read